Browsing by Author "Wallace, Melissa"

Now showing 1 - 3 of 3
  • Thumbnail Image
    Item
    Open Access
    Knowledge, Perceptions and Attitudes of Young Adults Towards Electronic-cigarettes
    (2019) Mhazo, Pakhani; Swartz, Alison; Wallace, Melissa
    Electronic cigarettes (e-cigarettes) are deemed to be safer than tobacco cigarettes because they do not contain a number of toxicants and carcinogens that are present in tobacco cigarettes. However, their long-term health effects are unknown. Despite concerns surrounding this, there has been a rapid market penetration of e-cigarettes worldwide. South Africa has no legislation which specifically controls the marketing, sale and use of e-cigarettes and concerns have been raised over the increasing use of e-cigarettes by youth, who are often attracted to these novel products. This study is one of the first studies to explore the knowledge and perceptions of ecigarettes in South Africa. A qualitative approach was used to explore young adults’ perceptions, attitudes and behaviour related to e-cigarettes and assess the factors that shape those perceptions. The sources from which the participants accessed e-cigarette-related information were also explored. The study was conducted at the University of Cape Town and participants were registered male and female students at the university. Focus group discussions and individual interviews were used to collect data and thematic analysis approach was used to analyse the data. The results show that participants generally perceived e-cigarettes as healthier than tobacco cigarettes despite showing limited knowledge of the chemical constituents of e-cigarette liquid. Rather, the majority of the participants felt e-cigarettes were safer because of the pleasant smell. A pleasant smell from e-cigarettes was associated with health and the unpleasant smell was associated with danger. E-cigarettes were also viewed as a symbol of social status. The study recommends that e-cigarette awareness should be increased, and e-cigarettes should be regulated as tobacco products to alter the perception that they are safe.
  • No Thumbnail Available
    Item
    Open Access
    Oral PrEP use among pregnant or parenting young women in South Africa: evidence from a large community-based implementation study
    (2026) Chen-Charles, Jenny Davey, Dvora J. Rousseau, Elzette Little, Francesca Toska, Elona Mathola, Ntombovuyo Macdonald, Pippa Vanto, Onesimo Wallace, Melissa Bekker, Linda-Gail; Davey, Dvora J; Rousseau, Elzette; Little, Francesca; Toska, Elona; Mathola, Ntombovuyo; Macdonald, Pippa; Vanto, Onesimo; Wallace, Melissa; Bekker, Linda-Gail, Melissa
    Abstract Background The risk of HIV acquisition is heightened during pregnancy and early parenthood with the additional risk of vertical HIV transmission. While recent studies have improved our understanding of PrEP use among pregnant and breastfeeding women, further evidence is needed to inform the design of interventions that support sustained use, especially among young women who are pregnant or parenting. Methods We analysed data from young women aged 15–29 years who initiated PrEP in an implementation study (FastPrEP) in Cape Town, South Africa. Logistic regression was used to examine the association between pregnancy or parenting status (≥ 1 living child) and PrEP discontinuation at 1- and 4-months post-initiation, based on pharmacy refill data. The primary exposure was currently pregnant or having a child (vs. not); secondary analyses stratified by age (15–24 vs. 25–29 years) among women who were pregnant/parenting. Models were adjusted for age and hypothesised explanatory factors were included in sensitivity analysis: service delivery location, contraceptive use, HIV risk perception, and relationship status. Results Between August 2022 and June 2024 n = 4,876 young women initiated PrEP; 44% were pregnant/parenting (of which 10% were pregnant), and the median age was 21.6 years (IQR:18–25). At 1-month, women who were pregnant/parenting had higher odds of PrEP discontinuation (aOR:1.30, 95% CI:1.14–1.49). At 4-months this relationship persisted (aOR:1.41, 95% CI:1.12–1.78) compared with non-pregnant/parenting women. Among those pregnant/parenting, younger women (15–24 years) had higher odds of discontinuation at 1-month (aOR:1.31, 95% CI:1.08–1.58) and 4-months (aOR:1.41, 95%CI:1.02–1.96) compared to women aged 25–29. In the fully adjusted multivariable model, receiving PrEP in mobile clinics (aOR:0.71, 95% CI:0.61–0.82) vs. government clinics was associated with lower odds of early discontinuation. Conclusion Young women who are pregnant/parenting face elevated risk of early PrEP discontinuation. Differentiated, life-stage and youth-responsive interventions, such as counselling, partner involvement, and integration with maternal and child health, or sexual and reproductive health services, are critical to improving PrEP persistence among this priority population. This population should be prioritised in the rollout of long-acting PrEP formulations, which may better align with their needs and reduce the burden of daily adherence.
  • Thumbnail Image
    Item
    Open Access
    A qualitative analysis of factors influencing HPV vaccine uptake in Soweto, South Africa among adolescents and their caregivers
    (Public Library of Science, 2013) Katz, Ingrid T; Nkala, Busisiwe; Dietrich, Janan; Wallace, Melissa; Bekker, Linda-Gail; Pollenz, Kathryn; Bogart, Laura M; Wright, Alexi A; Tsai, Alexander C; Bangsberg, David R
    BACKGROUND: In South Africa, the prevalence of oncogenic Human Papillomavirus (HPV) may be as high as 64%, and cervical cancer is the leading cause of cancer-related death among women. The development of efficacious prophylactic vaccines has provided an opportunity for primary prevention. Given the importance of psycho-social forces in vaccine uptake, we sought to elucidate factors influencing HPV vaccination among a sample of low-income South African adolescents receiving the vaccine for the first time in Soweto. METHODS: The HPV vaccine was introduced to adolescents in low-income townships throughout South Africa as part of a nationwide trial to understand adolescent involvement in future vaccine research targeting human immunodeficiency virus (HIV). We performed in-depth semi-structured interviews with purposively-sampled adolescents and their care providers to understand what forces shaped HPV vaccine uptake. Interviews were recorded, transcribed, translated, and examined using thematic analysis. RESULTS: Of 224 adolescents recruited, 201 initiated the vaccine; 192 (95.5%) received a second immunization; and 164 (81.6%) completed three doses. In our qualitative study of 39 adolescent-caregiver dyads, we found that factors driving vaccine uptake reflected a socio-cultural backdrop of high HIV endemnicity, sexual violence, poverty, and an abundance of female-headed households. Adolescents exercised a high level of autonomy and often initiated decision-making. Healthcare providers and peers provided support and guidance that was absent at home. The impact of the HIV epidemic on decision-making was substantial, leading participants to mistakenly conflate HPV and HIV. CONCLUSIONS: In a setting of perceived rampant sexual violence and epidemic levels of HIV, adolescents and caregivers sought to decrease harm by seeking a vaccine targeting a sexually transmitted infection (STI). Despite careful consenting, there was confusion regarding the vaccine's target. Future interventions promoting STI vaccines will need to provide substantial information for participants, particularly adolescents who may exercise a significant level of autonomy in decision-making.